Singapore legislation

Schedule 4

of Human Biomedical Research Act 2015

Schedule 4

Restricted human biomedical research

FOURTH SCHEDULESections 2, 31(1) and 62(1) and paragraph 1 of Third ScheduleRestricted human biomedical research

1. Human biomedical research involving human eggs or human embryos.

2. Human biomedical research involving —

(a)

the following types of human-animal combination embryos:

(i)

cytoplasmic hybrid embryos;

(ii)

human-animal combination embryos created by the incorporation of human stem cells (including induced pluripotent stem cells);

(iii)

human-animal combination embryos created in-vitro by using —

(A)

human gametes and animal gametes; or

(B)

one human pronucleus and one animal pronucleus;

(b)

the introduction of human stem cells (including induced pluripotent stem cells) into a prenatal animal foetus or animal embryo;

(c)

the introduction of human pluripotent stem cells (including induced pluripotent stem cells) into a living postnatal animal but excludes the introduction of such human pluripotent stem cells into immunodeficient mice solely for the analysis of teratoma induction;

(d)

the introduction of human stem cells (including induced pluripotent stem cells) or human neural cells into the brain of a living postnatal animal; or

(e)

any entity created as a result of any process referred to in sub‑paragraphs (b), (c) and (d).

3. Nothing in this Schedule is to be construed to permit any human biomedical research that is prohibited under the Third Schedule.[S 623/2017]

Read in full context — Human Biomedical Research Act 2015 →